0OB3.LSE Valneva SE

Healthcare Oil, Gas & Consumable Fuels London Exchange
2.77 EUR
Close of Oct 3, 2026
2.03 5.15
Market cap
EUR 212M
P/E
-
P/B
-
ROE
-156.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0OB3.LSE undervalued?

Graham number

The Graham number of Valneva SE cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Valneva SE fundamental analysis

No fundamental analysis for Valneva SE yet.

Valneva SE stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Valneva SE

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, …

Full company profile